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  N’Ve calculated the volume ofpulmonary metastasis ofurological cancer． The volume ofmetastasis
was then plotted against time to assess the response to the treatment． At the same time several ser’um
markers were measured．
  The volume of pulmonary metastasis changed in parallel with serum markers． Therefore the
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Fig．5．左＝初診時
    右＝化学療法施行3ヵ月後
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1）J．Ellert：Timing of administration of 5－Fluo－
 rouracil in combination with irradiation in the
 treatment of advanced adenocarcinoma． S．A．
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